Subscribe free

Sarcoma & rare tumors ·

Management and Prognosis of Gastric Neuroendocrine Tumors

Gastric neuroendocrine tumors (G-NETs) are rare tumors originating from the gastric mucosa, classified into three subtypes based on their characteristics and behavior. Type 1 and 2 are typically multifocal and associated with elevated serum gastrin levels. Type 2 causes symptoms like abdominal pain and diarrhea. Type 3, sporadic and solitary, has the most aggressive phenotype. Treatment and prognosis vary based on tumor type, size, and stage, with type 1 having the best prognosis and type 3 having the worst. A comprehensive review discusses the presentation, workup, and surgical management of G-NETs.

Review by Sok C, Ajay PS (…) Shah MM et 2 al. in Ann Surg Oncol

© 2023. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Sarcoma & rare tumors.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Sarcoma & rare tumors

The latest stitches

Ann Surg Oncol26 Oct 2026

SSTR PET finds more distant disease in GEP-NETs

In this 24-year surgical cohort, SSTR PET identified bone and retroperitoneal nodal metastases more often than Octreoscan—findings that may matter for operative planning.

Ann Surg Oncol11 May 2026

Mapping Surgical Evidence for GEP-NETs

Surgical management of gastro-entero-pancreatic neuroendocrine tumors is inconsistent, highlighting the need for clearer guidelines.

All papers in Sarcoma & rare tumors →